Asensus Surgical

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Asensus Surgical reports Q1 loss but eyes stability through acquisition

Asensus Surgical's Q1 2024 performance showed a significant net loss, but the potential acquisition by KARL STORZ offers financial stability. The company aims to sustain operations into Q3 2024 and beyond with available cash and additional financing. Ongoing initiatives focus on advancing surgical systems and expanding global programs.

Asensus Surgical reports Q2 losses, merger vote adjourned

Asensus Surgical faces financial struggles with a significant net loss and liquidity concerns.
The proposed merger with Karl Storz offers a potential strategic advantage but hinges on stockholder approval.
Addressing operational inefficiencies and investor engagement are critical for long-term success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Asensus Surgical is a digital interface between the surgeon and patient to improve minimally invasive surgery through digital laparoscopy. They enable capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seek to address the current clinical, cognitive, and economic shortcomings in surgery.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2021. Recent Highlights Record quarter for procedures performed using Senhance® Surgical Systems, growing 47% over the prior year Four Senhance Surgical Programs recently initiated, thr

Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2021

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Shinmatsudo Central General Hospital in Matsudo, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are excited to partner with the Shinmatsudo Central General Hospital, which has extensive experience

Asensus Surgical Announces Shinmatsudo Central General Hospital in Japan to Initiate Senhance Robotic Surgical System

Asensus Surgical (ASXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Asensus Surgical (ASXC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 third quarter financial and operating results after the market closes on Wednesday, November 3, 2021. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call wi

Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 3, 2021

IAMGOLD

McEwen Mining

Reddit penny stocks continue to attract new investors, here's three to watch The post Hot Reddit Penny Stocks to Watch Right Now? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Hot Reddit Penny Stocks to Watch Right Now? Check These 3 Out

Vinco Ventures

Globalstar

Mind Medicine MindMed

SNDL Inc.

Uranium Energy

Exela Technologies

They're not exactly names you want to bet the ranch on. Still, a $100 position in each of these penny stocks could be worth the risk.

7 Penny Stocks to Pick Up if You Have $100 to Spare

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Hirosaki University Hospital has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are excited to add a system at Hirosaki University Hospital to help build out its Senhance Robotic Surgery Program,” said Anthony

Asensus Surgical, Inc. Announces Hirosaki University Hospital to Initiate Senhance Robotic Surgery Program

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Paul LaViolette, who has served as the Company's Board Chair since 2013, will step down as Chair in late October, and intends to leave the Board before the end of the year. Mr. LaViolette has informed the Board of his intention to leave t

Asensus Surgical Announces Board Chair Transition

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Sapporo Medical University Hospital, located in Hokkaido, Japan, has entered into an agreement to lease and utilize a Senhance® Surgical System. “The Department of Surgery, Surgical Oncology and Science at Sapporo Medical University Hospital i

Asensus Surgical, Inc. Announces Sapporo Medical University Hospital in Japan to Initiate Senhance Robotic Surgery Program

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Loginov Moscow Clinical Scientific Center, located in Moscow, Russia, has initiated its Senhance® Robotic Surgery program following the purchase of a Senhance Surgical System. The installation represents the first Senhance Surgical System

Asensus Surgical Announces Purchase of Senhance Robotic System by Loginov Moscow Clinical Scientific Center

Intuitive Surgical

Medtronic

Stryker

Watch out for the likes of Asensus Surgical (ASXC), Stryker (SYK), Medtronic (MDT) and Intuitive Surgical (ISRG) as demand for surgical robots is set to rise, owing to the conveniences they offer.

4 Stocks to Watch as Demand for Surgical Robots Ready to Rise

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at three upcoming virtual investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference Recorded presentation available for on-demand listening beginning Monday, September 13, 2021, at 7:00 am Eastern Time Presentation For

Asensus Surgical, Inc. to Participate in Three Upcoming Virtual Healthcare Conferences

Electrameccanica

China Rapid Finance

With September off to a bullish start for penny stocks, which small-caps are you watching right now? The post Hot Penny Stocks to Buy Now?

Hot Penny Stocks to Buy Now? 4 to Watch As the Market Turns Bullish

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that it has received 510(k) clearance from the FDA for an expansion of machine vision capabilities on the previously cleared Intelligent Surgical Unit™ (ISU™). The ISU is utilized with the Company's SenhanceⓇ Surgical System which enables Digital

Asensus Surgical Receives FDA 510(k) Clearance for Expansion of Machine Vision Capabilities

Asensus' Senhance robotic platform helps surgeons with high-precision tasks, without necessarily crowding the operation room during COVID times. Given the favorable response and feedback from surgeons, the company anticipates to sell more of its systems and accessories.

Asensus: Consider The Whole Picture

BIOLASE

Oragenics

Trading biotech penny stocks? Here's 3 you don't want to miss The post 3 Biotech Penny Stocks To Watch Making Big Waves in 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Biotech Penny Stocks To Watch Making Big Waves in 2021

Asensus Surgical, Inc. (ASXC) CEO Anthony Fernando on Q2 2021 Results - Earnings Call Transcript

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the second quarter 2021. Recent Highlights Signed two lease agreements with hospitals to install Senhance® Surgical Systems Over 1,000 global procedures performed using Senhance during the first half of

Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2021

Will Asensus Surgical (ASXC) Report Negative Earnings Next Week? What You Should Know

Asensus Surgical Inc (NYSE: ASXC) has received FDA 510(k) clearance for 5 mm diameter articulating instruments, adding to the Senhance Surgical System technology platform.  Articulating instruments offer better access to difficult-to-reach areas of the anatomy by providing two additional degrees of freedom.

Asensus Surgical Stock Gains On FDA Approval For Articulating Instruments For Its Surgical System

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that it has received FDA 510(k) clearance for 5 mm diameter articulating instruments, adding to the Senhance Surgical System technology platform. Articulating instruments offer better access to difficult-to-reach areas of the anatomy by providing

Asensus Surgical Receives FDA 510(k) Clearance for Articulating Instruments

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing two new board members, Elizabeth Kwo, MD and Kevin Hobert, effective immediately. “We are delighted to welcome two accomplished industry veterans to our Board of Directors, each of whom bring

Asensus Surgical Announces the Appointment of Two New Board Members

Jaguar Health

Why these biotech penny stocks are seeing heightened momentum right now The post Could These Biotech Penny Stocks Explode in August 2021? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Could These Biotech Penny Stocks Explode in August 2021?

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 second quarter financial and operating results after the market closes on Thursday, August 5, 2021. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will

Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 5, 2021

After Asensus Surgical joined the Russell 2000 index last month, the stock climbed higher but has since fallen back to earth.

News for Asensus Surgical Stock (ASXC)